Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity

MLA

Jing Pan, et al. “Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity.” IScience, vol. 3, no. 192–207, May 2018, pp. 192–207. EBSCOhost, https://doi.org/10.1016/j.isci.2018.04.013.

APA

Jing Pan, Yongik Lee, Gang Cheng, Jacek Zielonka, Qi Zhang, Martina Bajzikova, Donghai Xiong, Shirng-Wern Tsaih, Micael Hardy, Michael Flister, Christopher M. Olsen, Yian Wang, Ole Vang, Jiri Neuzil, Charles R. Myers, Balaraman Kalyanaraman, & Ming You. (2018). Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity. IScience, 3(192–207), 192–207. https://doi.org/10.1016/j.isci.2018.04.013

Chicago

Jing Pan, Yongik Lee, Gang Cheng, Jacek Zielonka, Qi Zhang, Martina Bajzikova, Donghai Xiong, et al. 2018. “Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity.” IScience 3 (192–207): 192–207. doi:10.1016/j.isci.2018.04.013.